Antibody data
- Antibody Data
- Antigen structure
- References [9]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 66410-1-Ig - Provider product page
- Provider
- Proteintech Group
- Product name
- SIRT2 antibody
- Antibody type
- Monoclonal
- Description
- SIRT2 antibody (Cat. #66410-1-Ig) is a mouse monoclonal antibody that shows reactivity with human, mouse, rat, pig and has been validated for the following applications: IF, IHC, WB,ELISA.
- Reactivity
- Human, Mouse, Rat, Porcine
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 1D8G10
- Vial size
- 20ul, 150ul
Submitted references Identification of Circulating Inflammatory Proteins Associated with Calcific Aortic Valve Stenosis by Multiplex Analysis.
FBXO31 is upregulated by METTL3 to promote pancreatic cancer progression via regulating SIRT2 ubiquitination and degradation.
Spinal sirtuin 2 attenuates bone cancer pain by deacetylating FoxO3a.
Development of a multiplex assay to assess activated p300/CBP in circulating prostate tumor cells.
SIRT2 promotes cell proliferation and migration through mediating ERK1/2 activation and lactosylceramide accumulation in prostate cancer.
Bacterial infection promotes tumorigenesis of colorectal cancer via regulating CDC42 acetylation.
Proteomic analysis of the effects of caffeine in a neonatal rat model of hypoxic-ischemic white matter damage.
Nicotinamide riboside alleviates cisplatin-induced peripheral neuropathy via SIRT2 activation.
A redox-mediated conformational change in NQO1 controls binding to microtubules and α-tubulin acetylation.
Lin R, Zhu Y, Chen W, Wang Z, Wang Y, Du J
Cardiovascular toxicology 2024 May;24(5):499-512
Cardiovascular toxicology 2024 May;24(5):499-512
FBXO31 is upregulated by METTL3 to promote pancreatic cancer progression via regulating SIRT2 ubiquitination and degradation.
Chen K, Wang Y, Dai X, Luo J, Hu S, Zhou Z, Shi J, Pan X, Cao T, Xia J, Li Y, Wang Z, Ma J
Cell death & disease 2024 Jan 12;15(1):37
Cell death & disease 2024 Jan 12;15(1):37
Spinal sirtuin 2 attenuates bone cancer pain by deacetylating FoxO3a.
Yang C, Kang F, Huang X, Wu W, Hou G, Zheng K, Han M, Kan B, Zhang Z, Li J
Biochimica et biophysica acta. Molecular basis of disease 2024 Apr;1870(4):167129
Biochimica et biophysica acta. Molecular basis of disease 2024 Apr;1870(4):167129
Development of a multiplex assay to assess activated p300/CBP in circulating prostate tumor cells.
Filon M, Yang B, Purohit TA, Schehr J, Singh A, Bigarella M, Lewis P, Denu J, Lang J, Jarrard DF
Oncotarget 2023 Jul 20;14:738-746
Oncotarget 2023 Jul 20;14:738-746
SIRT2 promotes cell proliferation and migration through mediating ERK1/2 activation and lactosylceramide accumulation in prostate cancer.
Lin R, Yang Y, Wu E, Zhou M, Wang S, Zhang Q
The Prostate 2023 Jan;83(1):71-81
The Prostate 2023 Jan;83(1):71-81
Bacterial infection promotes tumorigenesis of colorectal cancer via regulating CDC42 acetylation.
Wang DN, Ni JJ, Li JH, Gao YQ, Ni FJ, Zhang ZZ, Fang JY, Lu J, Yao YF
PLoS pathogens 2023 Feb;19(2):e1011189
PLoS pathogens 2023 Feb;19(2):e1011189
Proteomic analysis of the effects of caffeine in a neonatal rat model of hypoxic-ischemic white matter damage.
Yang L, Yu X, Zhang Y, Liu N, Li D, Xue X, Fu J
CNS neuroscience & therapeutics 2022 Jul;28(7):1019-1032
CNS neuroscience & therapeutics 2022 Jul;28(7):1019-1032
Nicotinamide riboside alleviates cisplatin-induced peripheral neuropathy via SIRT2 activation.
Acklin S, Sadhukhan R, Du W, Patra M, Cholia R, Xia F
Neuro-oncology advances 2022 Jan-Dec;4(1):vdac101
Neuro-oncology advances 2022 Jan-Dec;4(1):vdac101
A redox-mediated conformational change in NQO1 controls binding to microtubules and α-tubulin acetylation.
Siegel D, Bersie S, Harris P, Di Francesco A, Armstrong M, Reisdorph N, Bernier M, de Cabo R, Fritz K, Ross D
Redox biology 2021 Feb;39:101840
Redox biology 2021 Feb;39:101840
No comments: Submit comment
No validations: Submit validation data